Stockscreener 앱 받기
1.13
35.06%
-0.61
전일 마감가:
$1.74
열려 있는:
$1.35
하루 거래량:
19.81M
Relative Volume:
13.51
시가총액:
$78.07M
수익:
$65,300
순이익/손실:
$-84.95M
주가수익비율:
-0.5845
EPS:
-1.9332
순현금흐름:
$-88.92M
1주 성능:
-27.10%
1개월 성능:
-35.06%
6개월 성능:
-54.07%
1년 성능:
-31.93%
1일 변동 폭
$1.065
$1.36
1주일 범위
$1.065
$1.785
52주 변동 폭
$1.065
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
명칭
Inovio Pharmaceuticals Inc
전화
(858) 410-3134
주소
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.13 | 78.07M | 65,300 | -84.95M | -88.92M | -1.9332 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2024-01-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-11-09 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2022-11-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 재개 | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 재개 | Jefferies | Hold |
| 2021-09-10 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 개시 | Jefferies | Hold |
| 2021-03-23 | 개시 | BofA Securities | Neutral |
| 2021-02-12 | 개시 | Oppenheimer | Outperform |
| 2020-11-17 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-11-10 | 업그레이드 | ROTH Capital | Sell → Neutral |
| 2020-09-28 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-01 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-07-01 | 다운그레이드 | ROTH Capital | Neutral → Sell |
| 2020-06-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-21 | 개시 | The Benchmark Company | Buy |
| 2020-04-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2020-03-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 개시 | ROTH Capital | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
| 2017-10-18 | 개시 | RBC Capital Mkts | Outperform |
| 2017-09-06 | 개시 | Citigroup | Buy |
| 2017-06-08 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 재확인 | Maxim Group | Buy |
| 2017-03-16 | 업그레이드 | Maxim Group | Hold → Buy |
| 2017-03-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
모두보기
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO - GlobeNewswire Inc.
ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Inovio Pharmaceuticals stock tumbles on dilutive offering By Investing.com - Investing.com Canada
Inovio Pharmaceuticals stock tumbles on dilutive offering - Investing.com
Inovio Plummets 34.5%: Biotech's Volatile Move Sparks Market Alert - Bitget
What's Behind The Drop In Inovio Pharmaceuticals Stock Today? - Benzinga
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) ... - Bluefield Daily Telegraph
Inovio Faces New SEC Scrutiny Amidst Stock Sale Plans - stockstotrade.com
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain OfficersINO - PR Newswire
Inovio announces pricing of $17.5 million public offering - MarketScreener
Inovio prices $17.5 million public offering of shares and warrants - MSN
Inovio prices $17.5M stock offering with warrants - Investing.com
INOVIO sells 12.5M shares and warrants in $17.5M financing - Stock Titan
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program - TipRanks
[424B5] INOVIO PHARMACEUTICALS, INC. Prospectus Supplement (Debt Securities) - Stock Titan
Inovio Pharmaceuticals suspends at-the-market offering prospectus - investing.com
According to the latest filings from the US Securities and Exchange Commission (SEC), biotechnology company Inovio Pharmaceuticals has officially suspended and terminated its at-the-market (ATM) equity offering prospectus previously established with inve - Bitget
Inovio suspends ATM prospectus after $3.2M sold under program - TradingView
Inovio (NASDAQ: INO) suspends ATM prospectus after selling 1.32M shares - Stock Titan
Inovio Pharmaceuticals proposes securities offering - MSN
Biotech INOVIO seeks buyers for stock plus two warrant series - Stock Titan
INOVIO to Participate in Upcoming Scientific Conference - Sahm
Inovio announces proposed public offering of stock and warrants By Investing.com - Investing.com Canada
INOVIO Announces Proposed Public Offering - PR Newswire
INOVIO (NASDAQ: INO) CMO converts RSUs; 1,223 shares withheld for taxes - Stock Titan
INOVIO to show mouse hemophilia treatment data on April 22 - Stock Titan
Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your RightsINO - PR Newswire
INO SEC FilingsInovio Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO - ChartMill
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - GlobeNewswire
INO Stock Price, Quote & Chart | INOVIO PHARMACEUTICALS INC (NASDAQ:INO) - ChartMill
Inovio Pharmaceuticals Faces Investor Deadline - National Today
Volume Summary: Is Inovio Pharmaceuticals Inc a top pick in the sectorWeekly Trend Report & Smart Investment Allocation Tips - baoquankhu1.vn
INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
Levi & Korsinsky Reminds Inovio Pharmaceuticals, Inc. - GlobeNewswire
Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
INO STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inovio Pharmaceuticals, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmace - GuruFocus
INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 - ChartMill
Aug Fed Impact: Whats the MACD signal for Inovio Pharmaceuticals Inc2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
INO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inovio Pharmaceuticals Inc. Investors ... - Caledonian Record
KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate - The Globe and Mail
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire
INO Shareholder Alert: Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit Investors ... - Bluefield Daily Telegraph
INO Shareholder Alert: Inovio Pharmaceuticals, Inc. - GlobeNewswire
Inovio Pharmaceuticals Inc (INO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
1.47%
자본화:
|
볼륨(24시간):